Compare Nomura Holdings Inc (NMR) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nomura Holdings Inc vs Koninklijke Philips NV — how do they compare? Nomura Holdings Inc trades at $10.82 (market cap $31.31B), while Koninklijke Philips NV trades at $24.94 (market cap $24.84B). The key difference: Nomura Holdings Inc is the larger of the two by market cap, and Koninklijke Philips NV pays the higher dividend (4.01%). Which is the better fit depends on your goals.
| NMR | PHG | |
|---|---|---|
Market Cap | $31.31B | $24.84B |
Sector | Financials | Health |
52-Week High | $10.65 | $32.91 |
52-Week Low | $6.73 | $25.02 |
Dividend Yield | 3.05% | 4.01% |
Enterprise Value | — | $31.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nomura Holdings (NMR) trades at $10.63, showing a slight 0.19% decline. The stock exhibits bullish technical signals with strong moving averages, though RSI levels suggest overbought conditions. Revenue surged to $1.66 trillion in 2025, with net income reaching $340.74 billion and a robust 20.4% margin. Recent earnings beat expectations in Q2 2026, but missed in prior quarters. Analyst sentiment is mixed with a 'Hold' consensus, while news highlights momentum in wholesale and wealth management segments.
Outlook remains cautiously optimistic due to solid profitability and growth, but risks include volatile cash flows, high debt levels, and competitive pressures. The stock's valuation at a P/E of 12.46 appears reasonable, yet investor caution is warranted given earnings inconsistencies and macroeconomic uncertainties affecting financial stocks.
PHG trades at $25.29, down 2.32% today, with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with Q2 2026 EPS of $0.57 beating expectations of $0.40, and positive net income of $895M in 2025 reversing previous losses. Recent product launches in women's health and AI-powered medical devices demonstrate innovation momentum.
The outlook is mixed with strong fundamentals and analyst support (36% buy ratings) offset by technical weakness. Key opportunities include margin expansion and new product adoption, while risks involve cybersecurity threats and competitive pressures in healthcare technology.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
